All In MedTech

Device Trial Radar · NCT04494035

AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System

Last checked: Nov 20, 2026Latest source record: Sep 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

7

Actual

Start

Jan 14, 2020

Primary completion

Oct 23, 2020

Study completion Oct 23, 2020

Sponsor

Lead sponsor
Medtronic EndovascularPublic (MDT)
Sponsor type
Industry
First posted
Jul 31, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, single-arm, non-blinded study, intending to treat and collect and evaluate data in up to ten (10) human subjects who are currently being treated with hemodialysis and who present with acute thrombosis in their arteriovenous (AV) grafts, treated with the CAPERE® Thrombectomy System.

Conditions

  • Arteriovenous Graft Thrombosis

Interventions

  • CAPERE Thrombectomy SystemDevice

    Arteriovenous graft thrombectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Endpoint (Effectiveness)Time frame: Intraoperative

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Health Network Toronto General

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.